Skip to main content
. 2018 Mar 13;5(4):e147–e160. doi: 10.1016/S2352-3026(18)30020-6

Table 5.

Causes and grade of adverse events by treatment periods

Intervention (n=71)
Washout (n=81) Total (n=152)
RUSF-v RUSF-b Total Washout 1 Washout 2 Total
Abscesses 0 0 0 1 moderate 0 1 1
Abdominal pain 0 1 moderate 1 2 moderate 0 2 3
Anaemia 0 0 0 1 moderate 0 1 1
Acid reflux 1 severe 0 1 0 0 0 1
Body weakness 0 0 0 1 mild 0 1 1
Chest tightness 1 severe 0 1 0 0 0 1
Chickenpox 1 moderate 0 1 1 moderate 0 1 2
Diarrhoea 1 moderate 0 1 0 3 moderate 3 4
Epigastric pain 0 0 0 1 severe 0 1 1
Fever with source 0 1 severe 1 1 mild 0 1 2
Fever without source 4 moderate 1 moderate 5 3 (2 moderate, 1 severe) 0 3 8
Headache 0 1 severe 1 0 0 0 1
Malaria 8 (1 mild, 2 moderate, 5 severe) 10 (1 mild, 8 moderate, 1 severe) 18 26 (2 mild, 16 moderate, 8 severe) 11 (9 moderate, 2 severe) 37 55
Measles 0 0 0 0 1 moderate 1 1
Muscle spasms 1 mild 0 1 0 0 0 1
Nosebleeds 0 1 moderate 1 0 0 0 1
Pulmonary tuberculosis 0 0 0 1 moderate 0 1 1
Stroke 1 moderate 0 1 0 0 0 1
Tonsilitis 2 moderate 0 2 1 mild 2 (1 moderate, 1 severe) 3 5
Upper respiratory tract infections 2 moderate 4 (1 mild, 3 moderate) 6 3 (1 mild, 1 moderate, 1 severe) 0 3 9
Urinary tract infections 0 0 0 3 (1 moderate, 2 severe) 1 mild 4 4
Vaso-occlusive pain 14 (2 mild, 5 moderate, 7 severe) 15 (1 mild, 10 moderate, 4 severe) 29 12 (1 mild, 3 moderate, 7 severe, 1 very severe) 5 (1 mild, 3 moderate, 1 severe) 17 46
Vomiting 1 mild 0 1 0 0 0 1
Wounds 0 0 0 0 1 severe 1 1
Total 37 34 71 57 24 81 152

RUSF=ready-to-use food supplement.